| Revision as of 23:07, 1 August 2022 editCitation bot (talk | contribs)Bots5,433,890 edits Alter: doi-broken-date. | Use this bot. Report bugs. | Suggested by AManWithNoPlan | #UCB_CommandLine← Previous edit |
Revision as of 16:01, 7 September 2022 edit undoCitation bot (talk | contribs)Bots5,433,890 edits Add: s2cid. Removed parameters. | Use this bot. Report bugs. | Suggested by AManWithNoPlan | #UCB_CommandLineNext edit → |
| Line 37: |
Line 37: |
|
| molecular_weight = |
|
| molecular_weight = |
|
}} |
|
}} |
|
'''Saruplase''' is a ] enzyme.<ref name="pmid10608024">{{cite journal |vauthors=Bär FW, Vermeer F, Michels R, etal |title=Saruplase in Myocardial Infarction |journal=J. Thromb. Thrombolysis |volume=2 |issue=3 |pages=195–204 |year=1995 |pmid=10608024 |doi= 10.1007/BF01062710|doi-broken-date=31 July 2022 }}</ref> |
|
'''Saruplase''' is a ] enzyme.<ref name="pmid10608024">{{cite journal |vauthors=Bär FW, Vermeer F, Michels R, etal |title=Saruplase in Myocardial Infarction |journal=J. Thromb. Thrombolysis |volume=2 |issue=3 |pages=195–204 |year=1995 |pmid=10608024 |doi= 10.1007/BF01062710|s2cid=24046264 }}</ref> |
|
|
|
|
|
It is closely related to ].<ref name="pmid15992082">{{cite journal |vauthors=Moser M, Bode C |title=Pharmacology and clinical trial results of saruplase (scuPA) in acute myocardial infarction |journal=Expert Opin Investig Drugs |volume=8 |issue=3 |pages=329–35 |date=March 1999 |pmid=15992082 |doi=10.1517/13543784.8.3.329 }}</ref> |
|
It is closely related to ].<ref name="pmid15992082">{{cite journal |vauthors=Moser M, Bode C |title=Pharmacology and clinical trial results of saruplase (scuPA) in acute myocardial infarction |journal=Expert Opin Investig Drugs |volume=8 |issue=3 |pages=329–35 |date=March 1999 |pmid=15992082 |doi=10.1517/13543784.8.3.329 }}</ref> |
